News
Vor Bio's surprise $4B revival deal for RemeGen's autoimmune drug triggers divergent stock reactions
For $45 million upfront, Vor Bio is gaining ex-China rights to RemeGen’s telitacicept, a first-in-class recombinant ...
In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...
Phil Helmick believed the Moravia baseball team could continue building on the success of a tremendous senior class. If the weather would just cooperate, the Mohawks might already be on the verge of a ...
IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published ...
UNIONBANK has partnered with GMG Productions to bring award-winning musicals and theatrical experiences to audiences for its ...
PureTech Heath founded clinical-stage biotech Vor Bio has entered into an exclusive license agreement with RemeGen to develop ...
The licensing deal for BAFF/APRIL inhibitor telitacicept, which also includes regulatory and commercial milestones exceeding ...
ABOUT GENERALIZED MYASTHENIA GRAVIS (gMG)Myasthenia gravis (MG) is an autoantibody disease in which the immune system mistakenly makes antibodies (e.g., anti-acetylcholine receptor [AChR], anti ...
The ITC compared all published Phase 3 data of these treatments, leveraging longitudinal results, and findings reinforce the importance of consistent, sustained disease control in managing a ...
The West Marshall softball team climbed back into second place in the Heart of Iowa Conference with a 7-2 win over Roland-Story on Wednesday night. The Trojans (15-8, 10-4) used a five-run fourth ...
Detailed price information for Graphene Manufacturing Group Ltd (GMG-X) from The Globe and Mail including charting and trades.
1d
MedPage Today on MSNMyasthenia Gravis in ChildrenMyasthenia gravis (MG) in children and adolescents to age 18 -- juvenile MG -- includes clinically significant developmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results